The reaction of Pt(SiHPh 2 ) 2 (dmpe) (dmpe ) 1,2-bis(dimethylphosphino)ethane) with Pd(PCy 3 ) 2 forms (Cy 3 P)Pd(µ-η 2 -HSiPh 2 ) 2 Pt(PCy 3 ) (1), which contains two diphenylsilyl ligands bridged to Pd and Pt centers. A comparison of the crystallographic results and the NMR spectra of 1 with those of [(Cy 3 P)Pd(µ-η 2 -HSiPh 2 )] 2 ( 3) and [(Cy 3 P)Pt(µ-η 2 -HSiPh 2 )] 2 (4) indicates that the structure of 1 contains two inequivalent Si-H hydrogens, Pd-H-Si and Pt-H-Si, with three-center twoelectron bonds.
The reaction of Pt(SiHPh 2 ) 2 (PEt 3 ) 2 with Pd(PEt 3 ) 3 produced heterodinuclear complexes with bridging diphenylsilyl ligands (Et 3 P)Pt(µ-η 2 -SiHPh 2 ) 2 Pd(PEt 3 ) (1) and (Et 3 P) 2 Pt-(µ-η 2 -SiHPh 2 ) 2 Pd(PEt 3 ) (2). Each product was isolated and fully characterized. X-ray crystallography of 2 and NMR spectra of 2 and 2-d 2 at 25 °C indicated the presence of two bridging SiHPh 2 (or SiDPh 2 ) ligands, which were bonded to one metal center via a M-Si single bond and to the other via a Si-H-M three-center, two-electron bond. The 1 H NMR spectrum of 2 at -90 °C exhibited a peak at δ -8.61 due to a hydrido ligand bonded to the Pt center, indicating the structure (Et 3 P) 2 PtH(µ-SiPh 2 )(µ-η 2 -SiHPh 2 )Pd(PEt 3 ) in the solution at low temperature. Complex 2 reacted with CN-t-Bu to form a mixture of (Et 3 P)(t-BuNC)-Pt(SiPh 2 -CH 2 -N(t-Bu)-SiPh 2 ) (3) and [(Et 3 P)(t-BuNC)Pt(µ-SiPh 2 )] 2 (4). Complex 3 contained the platinacyclopentane group, whose five-membered ring was composed of Pt, Si, N, and C atoms.Supporting Information Available: Crystallographic data of 1-4. This material is available free of charge via the Internet at http://pubs.acs.org. OM049858D
Late-transition-metal complexes with silylene (SiR 2 ) ligands have attracted considerable attention since the proposal of platinum-silylene intermediates in the [PtCl 2 (PEt 3 ) 2 ]-catalyzed reactions that convert organodisilanes into oligosilanes and the cyclic adducts into alkynes.[1] Mononuclear silylene complexes of platinum [2] and other late transition metals [3] were not isolated until some years later, probably because of the extremely high reactivity of most M = Si double bonds. Dinuclear complexes of late transition metals with bridging silylene ligands are more common.[4] The dinuclear platinum complex [{Pt(PR 3 )} 2 (m-SiHPh 2 ) 2 ] (PR 3 = PPh 3 , PCy 3 etc.) has been reported.[5] However, in spite of the stable coordination of bridging silylene ligands, complexes containing three or more metal atoms with bridging Si ligands have few precedents, [6] and those known are stabilized by electron-withdrawing CO and CNR ligands.[7] Braddock-Wilking and coworkers [8] and our group [9,10] have reported zero-valent triangular Pt 3 complexes, stabilized by bridging silylene and phosphine ligands. Chen, Shimada, and Tanaka employed 1,2-disilabenzene as a ligand and prepared trinuclear Pd complexes supported by the Si ligands.[11]Herein, we report the synthesis and unexpected structure of a planar tetranuclear Pd 0 complex with three bridging SiPh 2 ligands as well as facile exchange of the bridging silylene ligands to yield a dumbbell-shaped octapalladium complex composed of two Pd 4 units bridged by a diphosphine ligand. These complexes, composed of Pd 0 centers and electrondonating Si and phosphine ligands, possess a unique planar {Pd 4 Si 3 } core.Heating a mixture of a dipalladium complex with bridging diphenylsilyl ligands, [{Pd(PCy 3 )} 2 (m-h 2 -SiHPh 2 ) 2 ] (1), [12] The molecular structure of 2 was determined by singlecrystal X-ray diffraction (Figure 1). [14] Complex 2 has a hexagonal {Pd 4 Si 3 } core incorporating one central Pd atom,
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.